Interleukin-18 (IL-18) plays an important role in the innate and adaptive immune responses ([@bb0025]). IL-18 was originally identified as an IFN-gamma-inducing factor, structurally similar to IL-1, promoting Th1 type immune responses ([@bb0085], [@bb0050], [@bb0010]). Mice deficient in IL-18 have a blunted natural killer cell response and markedly reduced IFN-γ production ([@bb0030]).

The activity of IL-18 is via an IL-18 receptor (IL-18R) complex ([@bb0020]). This IL-18R complex is made up of IL-18 receptor alpha (IL-18Rα, formerly known as IL-1Rrp) and IL-18 receptor beta (IL-18Rβ, formerly known as IL-1RAcPL) to heterodimerize ([@bb0115], [@bb0065]). Both receptor chains belong to the IL-1 receptor family, and the binding of IL-18 to its receptor triggers signaling pathways is similar to IL-1 family members ([@bb0070]). Following exposure to IL-18, IL-18Rα recruits the IL-1 receptor activating kinase (IRAK) and TNFR-associated factor-6 (TRAF-6) ([@bb0070], [@bb0010]). The latter was important because it found to associate with the NF-κB-inducing kinase (NIK) ([@bb0080]).

IL-18 is a pro-inflammatory cytokine that is produced from T lymphocytes and macrophages and enhanced by cytotoxicity of natural killer cells ([@bb0025]). It can also cause severe allergic inflammatory reactions ([@bb0120]). IL-18BP is a circulating protein with high affinity for IL-18 and can neutralize its bioactivity ([@bb0030], [@bb0040]). IL-18BP acts as a natural inhibitor of IL-18 induced IFN-γ and suppresses the Th1 response ([@bb0005], [@bb0035]). In fact, the severity of autoimmune diseases appeared to be affected by the relative levels of IL-18 and IL-18BP ([@bb0075], [@bb0100]). IL-18BP has been shown to prevent or attenuate disease development in various mouse models ([@bb0100]). [@bb0125] reported that rhesus macaques IL-18BP was functional and could significantly reduce murine IL-18 and LPS-induced IFN-γ production by murine splenocytes. IL-18BP had been used safely in humans and clinical trials of IL-18BP as well as neutralizing anti-IL-18 antibodies ([@bb0040]).

As well known the giant panda (*Ailuropoda melanoleuca*) is one of the most endangered animals ([@bb0110]). The wild population is estimated \< 3,000 at present ([@bb0130]). Diseases are probably the greatest threats giant panda, especially virus diseases. Previous studies had shown that canine distemper virus (CDV), canine parvovirus (CPV) and canine coronavirus (CCV) had been detected from the giant pandas ([@bb0105], [@bb0090]). IL-18BP shows a great potential for the treatment of allergy ([@bb0065]). There are several reports that IL-18BP can prevent or attenuate the development of disease in animal models ([@bb0045], [@bb0015], [@bb0095]). So it is important to study the immune function genes of IL-18BP of giant panda, which will be helpful to protect giant panda on etiology and immunology.

Therefore, this study aimed to clone and characterize IL-18BP of giant panda.

The cDNA of IL-18BP of giant panda was amplified by RT-PCR. Total RNA was isolated from spleen sample of giant panda (natural death, Chengdu, Sichuan, China) by TRIzol reagent (Invitrogen, CA, USA) according to manufactures\' instructions. Remaining DNA was removed by DNase I (Fermentas, Canada). 1 μg of total RNA, Oligo (dT)~18~ and M-MLV reverse transcriptase (Invitrogen, CA, USA) was used in cDNA synthesis. The primers for giant panda IL-18BP were listed in Supplementary Table S1. All primers used for PCR and sequencing were made by Invitrogen (China). The products were ligated to the pMD18-T vector (TaKaRa, Dalian, China) and transformed into *Escherichia coli* JM109 competent cells. The bacteria were grown on LB plates with ampicillin and X-Gal. The plasmids were selected and tested by PCR and enzyme digestion with *Eco*R I and *Pst* I (TaKaRa, China), followed by sequencing (Huada Genomics Technology Co. Ltd., Beijing, China). The recombinant plasmid was named as pMD-AmIL18-BP. The results showed that the open reading frame (ORF) of the giant panda IL-18BP was 567 bp in length and encoded 188 amino acid residues (GenBank accession no. [KM232608](ncbi-n:KM232608){#ir0005}), which containing 28 amino acid signal peptides. Thus, the mature peptide of AmIL-18BP was 160 amino acids, with the predicted molecular weight of 17.6 kDa. The theoretical pI was 9.23. Secondary structure predicted by Predict Protein and the structure of human IL-18 visualizes that the AmIL-18BP molecule was composed of eight β-strands and three α-helixes. Comparison of the amino acid sequences of AmIL-18BP with human, mouse and Rhesus monkey showed 68.28%, 65.56% and 66.84% sequence identity, respectively. The sequence was conserved among giant panda, rhesus, human, and murine proteins within the middle portion of the amino acid sequence from residues 66 to 130 (Supplementary Fig. S1).To better determine the evolutionary position of AmIL-18BP, a phylogenetic tree was constructed by use of the genome data of other animals. AmIL-18BP clustered with dog IL-18BP (Supplementary Fig. S2).

In order to detect the isoforms of giant panda IL-18BP, RACE amplifications of 3′ ends was performed. Human IL-18BP gene encodes for at least four distinct isoforms (IL18BPa, b, c and d) derived from mRNA splice variants isolated from several cDNA libraries ([@bb0055]). IL-18BP sequences differed primarily in their carboxyl termini whereas the N-terminal was identical ([@bb0060], [@bb0030]). Different isoforms of the human IL18BP, murine IL-18BP and rhesus IL-18BP shared 100% identity in the 5′-untranslated regions (5′-UTR) ([@bb0055], [@bb0030], [@bb0125]). So in this study, only 3′ RACE was used to test the polymorphisms of AmIL-18BP in the 3′-UTR. The first PCR were performed with primers of adaptor and 18BP outer-F (Supplementary Table S1) by conditions of 16 cycles of denaturation at 98 °C for 10 s, annealing at 55 °C for 5 s, and extension at 72 °C for 1 min. Then first PCR amplification products as template, the second PCR were performed with primers of adaptor and 18BP inner-R (Supplementary Table S1) by conditions of 30 cycles of denaturation at 98 °C for 10 s, annealing at 55 °C for 5 s, and extension at 72 °C for 1 min. The sequenced results showed that 3′-UTR was 183 bp with classical polyadenylation signal sequence AATAAA and AmIL-18BP gene had no other type. So we amplified only a single isoform from spleen of giant pandas.

To express and purify functional recombinant AmIL-18BP in *E. coli*, coding fragment of AmIL-18BP was amplified with primers and PCR products were digested with *Bam*HI and *Hind*III (Fermentas, Canada) (Supplementary Table S1). It was subcloned into vector pET-32a (+) (Novagen, USA) to construct prokaryotic expression plasmid pETAm-IL18BP. After the sequencing, the recombinant vector was transformed into *E. coli* strain BL21 (DE3). Positive clones were screened on LB broth containing ampicillin (100 μg/mL) and grown with shaking at 150 rpm for overnight at 37 °C. 2 mL culture was transferred into fresh LB medium and continued shaken at 150 rpm at 37 °C for about 2--3 h until the OD600 reached 0.6. IPTG (final concentration of 0.5 Mm) was added to the medium. After additional cultivation at 18 °C for 16 h, the bacteria were harvested by centrifugation at 4000 ×* g* for 10 min, and the pellet resuspended in 20 mM Tris-HCl buffer (pH 8.0).The supernatant was applied to the Ni Sepharose column, and purified using Histidine-6 tag peptide at N-terminus of this prokaryotic expression vector immobilized metal ion affinity chromatography (GE Healthcare, Sweden), following the manufacturer\'s recommendations. The concentration was determined by BCA Protein Assay Kit (Thermo Scientific, IL, USA). Then the purified samples were store at 4 °C with Protease Inhibitor Cocktail (Sigma-Aldrich, MO, USA). SDS-PAGE was performed with 5% stacking gel and 12%(v/v) resolving gel and the proteins were visualized by Coomassie brilliant blue R-250 (Amresco, USA).

The sequence encoding mature peptide was successfully inserted into the pET-32a (+) vector. After transformed in *E. coli* BL21 (DE3), and induced by IPTG, the supernatant of cell lysate was visualized by SDS-PAGE. Compared with control BL21 (DE3) cells and non-induced cell sharboring pET-AmIL18BP, fusion protein with molecular weight of 35.7 kDa was expressed in soluble form. Histidine-tagged fusion protein was loaded to the nickel affinity HisTrap HP column. After eluted from the column with lotion, a single band was displayed on the gel ([Fig. 1](#f0005){ref-type="fig"} ). The concentration of the purified PET-AmIL-18BP was approximately 0.5 mg/mL, according to BCA methods.Fig. 1AmIL-18BP protein expression and purification in *E. coli* BL21 (DE3).M, molecular weight marker; lane 1,cell lysates of *E. coli* BL21(DE3); lane 2, cell lysates of bacteria harboring pET-AmIL18BP without IPTG induction; lane 3, cell lysates of bacteria harboring pET-AmIL18BP with IPTG induction; lane 4, purified AmIL-18BP fusion protein.Fig. 1

To investigate the biological activity of AmIL-18BP, cytokine IFN-γ production was measured by real-time qPCR. Splenocytes were isolated from two C~57~B~l6~ mice, and resuspended at 2.5 × 10^6^  cells/mL in a 200 μL volume. 1 × 10^6^  cells/well were cultured in 24-well plates in RPMI-1640 with 10% FBS in triplicate. Then three groups were treated with recombinant giant panda IL-18 (PET-AmIL-18) (500 ng/mL) and PET-AmIL-18BP (500 ng/mL), and then PET-AmIL-18 (500 ng/mL) and PBS regarded as control groups. All of them were incubate for 24 h at 37 °C with 5% CO~2~. Collected the cell at 3 h, 6 h and 24 h. Total RNA was isolated from the cultured spleen lymphocytes using TRIzol reagent. cDNA synthesis and contaminate genomic DNA removing were performed by PrimeScript™ RT Reagent Kit with gDNA Eraser (TaKaRa, Dalian, China). Reverse transcription was reacted at 37 °C for 15 min and 85 °C for 5 s. Quantitative real-time PCR (qRT-PCR) was performed to check the concentration of IFN-γ. The PCR condition was 98 °C for 2 min, 40 cycles of 98 °C for 10 s, 60 °C for 10 s, and 68 °C for 30 s, followed a gradient temperature from 65 °C to 95 °C, generating a melting curve to validate only an objective product had been amplified. The relative expression levels of these transcripts were normalized to those of GAPDH using Bio-Rad CFX Manager and calculated using Livak methods (2^--ΔΔCT^). Data in response to media were converted to the fold relative to that of the PBS controls. The results were analyzed statistically using SSPS 18.0 software, P \< 0.05 considered as significantly different between control and treated groups.

Then mice spleen lymphocytes were treated with recombinant protein AmIL-18 and AmIL-18BP. The effect on cytokine IFN-γ production was measured by real-time qPCR. As shown in [Fig. 2](#f0010){ref-type="fig"} , together with AmIL-18BP, AmIL-18 significantly reduced the expression level of IFN-γ in mouse lymphocytes, 2--9 fold lower than that of PBS control in the 3--12 h time (P \< 0.01).Fig 2Inhibition of AmIL-18BP in IFN-γ production.Note: The asterisk indicated a statistically significant difference (\*\*P \< 0.01,\*P \< 0.05) compared with the control.Fig 2

In conclusion, we succeeded cloned, expressed and purified the recombinant giant panda IL-18BP proteins. Our data also demonstrated its biologic function on mouse lymphocytes. These results will be helpful to increase our knowledge of the biology of potential therapeutic value use for suppression of inflammatory responses induced by IL-18, which will promote the study of protecting giant panda on etiology and immunology.
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